Winona Review

Winona — Provider Profile

Overview

Winona is a women's telehealth platform founded in 2019 with a clinical focus on menopause and perimenopause. It offers hormone replacement therapy (HRT) as its primary service, with GLP-1 weight management added as a significant secondary program. All clinicians on the platform are female, which reflects a deliberate design choice for a demographic that often reports feeling dismissed or under-served in standard clinical settings. Winona serves women generally 40 and older.

The platform operates primarily asynchronously, with follow-up video consultations available. The intake process collects a detailed hormonal and metabolic history, which means providers can connect weight concerns to the broader hormonal picture rather than treating GLP-1 prescribing as a standalone transaction. GLP-1 program pricing is estimated at $150–250 per month as of April 2026; verify current rates at bywinona.com, as pricing depends on medication type and dosage.

The clinical case for Winona's integrated model is genuine. Perimenopause and menopause create a cluster of metabolic changes — declining estrogen accelerates visceral fat accumulation, shifts insulin sensitivity, and alters appetite-regulating hormones — that meaningfully interact with GLP-1 pharmacology. A provider managing both HRT and a GLP-1 prescription can titrate each intervention with awareness of how they interact, rather than two siloed prescribers working without shared context. For women in this life stage who are considering GLP-1 therapy, a platform that co-manages hormonal and metabolic health is often more clinically appropriate than a generic telehealth GLP-1 mill. As of April 2026, note that compounded semaglutide's FDA shortage exemption has been rescinded; confirm which formulations Winona currently offers at the time of your consultation.

Medications Offered

• Compounded semaglutide (availability subject to current FDA regulatory status — confirm with Winona at time of consultation)
• Branded GLP-1 options (availability varies; verify at bywinona.com)
• Hormone replacement therapy: estradiol, progesterone, testosterone (core service)
• DHEA and other hormonal support therapies

Pricing

Service	Monthly Cost	What's Included
GLP-1 Weight Loss Program	~$150–250/mo	Medication, clinician oversight, messaging
HRT Program	Varies	Hormone therapy, ongoing management
Combined Program	Varies	GLP-1 + HRT co-management

Pricing estimated as of April 2026; verify current rates at bywinona.com. Costs vary by medication formulation and dosage level. Compounded medication pricing may differ from branded options — confirm availability and cost of each formulation directly.

States Served

Winona operates across most US states. Because it is a specialized women's health platform rather than a general primary care service, coverage in some states may be more limited than larger general telehealth providers. Confirm availability in your state at bywinona.com before registering.

Insurance

• Winona currently operates primarily on a cash-pay model for GLP-1 and hormone therapy services
• Some patients may be able to seek reimbursement through FSA/HSA accounts
• Insurance coverage for GLP-1 medications depends on the patient's individual plan formulary — Winona can provide documentation to support insurance claims in some cases

Consultation Process

Model: Async-first with follow-up video option

1. Complete a detailed intake form covering hormonal history, symptoms, weight history, and relevant labs
2. A licensed female clinician reviews your intake
3. Clinician responds via secure messaging with a treatment plan
4. Prescription sent to pharmacy or delivered (depending on medication type)
5. Ongoing messaging-based follow-up; video appointments available for complex cases or annual reviews

Pros

• Female-only clinician panel is a meaningful differentiator for the 40+ demographic
• Integrated HRT + GLP-1 co-management addresses the actual biology of perimenopause-related weight gain
• Detailed hormonal intake creates more clinical context than standard weight-loss telehealth intake forms
• Asynchronous model is accessible and does not require scheduling around rigid appointment slots
• Platform designed specifically for this population — not a general telehealth tool with a weight loss add-on

Cons

• Not appropriate for women outside the perimenopausal/menopausal demographic seeking GLP-1 treatment
• Cash-pay model with limited insurance integration means costs are fully out-of-pocket for most patients
• Compounded semaglutide availability is uncertain post-FDA enforcement; patients should confirm formulation options at time of consultation
• Async-first model may be insufficient for patients with complex or rapidly changing metabolic presentations
• Less brand recognition than larger platforms, which may make some patients hesitant despite clinical appropriateness

Best For

Winona is best suited to women in perimenopause or menopause who want to address weight management as part of a broader hormonal health picture. If you are already managing or considering HRT and are also a candidate for GLP-1 therapy, Winona's integrated model reduces the fragmentation that comes from using separate providers for each intervention. It is a stronger fit for the 40–65 age range than generic GLP-1 telehealth platforms that do not account for hormonal context.

Editorial Verdict

Winona fills a specific and underserved clinical niche. The overlap between perimenopause and GLP-1 candidacy is large — visceral weight gain, insulin resistance, and appetite dysregulation during this life stage are well-documented — and most telehealth platforms treat these as entirely separate problems requiring separate providers. Winona's model reflects a more clinically coherent approach for this population.

The main friction points are cost and formulation uncertainty. As a primarily cash-pay platform with pricing that can reach $250/month for GLP-1 medications, it is not the most affordable option. And with compounded semaglutide under FDA enforcement scrutiny as of 2025, patients need to verify what formulations are currently available before enrolling.

For the right patient — a woman in perimenopause or menopause, comfortable with telehealth, and interested in co-managed hormonal and metabolic care — Winona is a clinically well-reasoned choice that competitors in the GLP-1 space largely fail to replicate.

Related Content

• Who Qualifies for GLP-1 Medications?
• How Much Does Semaglutide Cost?
• How Much Does Tirzepatide Cost?

Winona Review 2026: HRT Telehealth for Menopause — Cost, Protocol & Honest Assessment

Medically reviewed by Telehealth Ally Medical Review Team. Pricing and protocol data last verified April 2026. We have no commercial relationship with Winona.

Winona is a telehealth platform for women seeking bioidentical hormone replacement therapy for menopause symptoms. It operates primarily through an async model — a physician reviews your symptom intake and prescribes a compounded hormone formulation — with monthly plans running $99–$199 depending on protocol. The platform works well for cash-pay patients who want accessible, low-friction BHRT; it is not the right fit for women with complex medical histories, those who want FDA-approved finished hormone products, or anyone who needs live video consultation with their prescriber.

Winona prescribes compounded bioidentical hormones — not FDA-approved finished HRT products. That distinction matters clinically and should factor into any decision. This review explains exactly what that means.

---

Who is Winona best for?

Winona fits a specific patient profile. Check whether it matches yours before starting the intake.

Winona is a good fit if you:

• Have classic menopause symptoms — hot flashes, night sweats, sleep disruption, vaginal dryness — and want to start BHRT
• Are comfortable with an async care model (questionnaire-based intake, messaging-based follow-up, no required video visit)
• Pay cash for healthcare and want an affordable monthly rate that includes the prescription and physician review
• Prefer compounded formulations with adjustable dosing over off-the-shelf standard products
• Are in otherwise good health without major cardiovascular risk factors, personal or family history of breast cancer, or complex hormone-related conditions

Look elsewhere if you:

• Want FDA-approved estradiol patches, pills, or progesterone capsules rather than compounded formulations
• Have a personal history of breast cancer, clotting disorders, stroke, or significant cardiovascular disease — these require in-person specialist involvement beyond what any async telehealth platform provides
• Need or want a live video consultation with your prescribing physician
• Have insurance that covers HRT and want to use it (Winona does not bill insurance)
• Want required hormone testing before your protocol is set — Winona makes lab work optional, not standard

See our best telehealth HRT platforms for menopause guide for a side-by-side comparison if you are still evaluating options.

---

How much does Winona cost?

Winona charges $99–$199/month for treatment, depending on the hormone protocol and specific compounded formulation prescribed. The monthly fee is all-in: it covers physician review, the compounded prescription, pharmacy dispensing, and shipping. Initial consultation and follow-up async messaging are included. There is no separate fee for the intake or prescription renewals.

Pricing last verified April 2026. We update pricing data monthly.

Component	Cost	Notes
Monthly treatment plan	$99–$199/month	Range depends on protocol and formulation
Initial consultation	Included	Async physician review of symptom questionnaire
Prescription and pharmacy fulfillment	Included	Compounded from licensed compounding pharmacy
Ongoing follow-up messaging	Included	Async; no video visits required
Quarterly check-ins	Included	Async review of symptoms and dose adjustments
Optional hormone lab panel	~$99 add-on	Not required to start treatment
Insurance billing	Not available	Cash-pay only

The pricing model is straightforward: one monthly fee with no hidden add-ons for standard care. The lab panel is the only meaningful upsell, and it is genuinely optional — Winona will prescribe without it. That said, starting treatment without baseline hormone levels is a real clinical limitation addressed in the protocol section below.

HSA/FSA eligibility for telehealth consultations varies. Check with your plan administrator if you intend to use those funds.

---

How does Winona's clinical protocol work?

Winona's care model has four stages: intake questionnaire, physician review, prescription dispatch, and ongoing async follow-up.

1. Symptom questionnaire

The intake covers menopause symptoms (hot flash frequency and severity, sleep, mood, libido, vaginal symptoms), medical history, current medications, and contraindications. There is no required video call. The questionnaire is the clinical basis for the initial prescription.

2. Physician review

A licensed physician — not a nurse practitioner or physician assistant — reviews the completed intake and prescribes a customized compounded hormone formulation based on the symptom profile. Winona's physician-only prescriber model is worth noting; many telehealth platforms route prescriptions through NPs or PAs operating from protocol templates.

3. Compounded prescription and delivery

The prescription goes to a licensed compounding pharmacy. Common formulations include compounded estriol/estradiol (topical cream or oral capsule), compounded progesterone, and compounded testosterone. Delivery methods — transdermal cream, oral, vaginal suppository — vary by patient. The pharmacy ships directly to you.

4. Ongoing follow-up

Winona's follow-up model is async messaging with quarterly physician check-ins. Symptom changes, dose adjustment requests, and questions go through the platform's messaging system. There are no required in-person or video visits. This keeps the cost model viable but also means dose titration happens through written communication rather than clinical interaction.

A note on personalization: Winona describes its approach as personalized BHRT. The personalization is real in the sense that dosing can be adjusted — but without required baseline hormone testing, the starting point is symptom-reported rather than lab-confirmed. If your symptoms suggest high estrogen but your labs show the opposite, symptom-only prescribing will land you on the wrong starting dose. The optional lab panel exists partly to address this; using it is worth considering.

---

What is the difference between compounded BHRT and FDA-approved HRT?

This distinction is the most clinically significant thing to understand before choosing Winona — or any compounded BHRT telehealth platform.

FDA-approved HRT options (estradiol patches, estradiol pills, vaginal estradiol rings, progesterone capsules like Prometrium) are manufactured products that have gone through the FDA's drug approval process. That process requires demonstrated safety and efficacy data from clinical trials, standardized manufacturing, and consistent dosing. These are the products recommended by major medical societies including the American College of Obstetricians and Gynecologists (ACOG) and the North American Menopause Society (NAMS) as first-line HRT options.

Compounded BHRT — what Winona prescribes — is prepared by licensed compounding pharmacies. Compounding is legal and regulated, but compounded drugs are not FDA-approved as finished products. Each batch is made for an individual patient. There is no FDA review of each formulation's safety, efficacy, or consistency. The molecular structure of bioidentical hormones (estradiol, estriol, progesterone) is identical to endogenous human hormones and to those in many FDA-approved products — the "bioidentical" label refers to that molecular structure, not to a regulatory or clinical standard.

Why this matters: The ACOG and NAMS position is that compounded BHRT lacks large-scale randomized trial safety data at specific custom doses. There is no robust clinical evidence that compounded formulations are safer, more effective, or better tolerated than FDA-approved options — despite frequent marketing claims to the contrary. Compounded products also carry real quality-control risks: contamination, potency variance, and inconsistent absorption.

This does not make compounded BHRT illegitimate. There are clinical situations where compounding is genuinely appropriate — patients with documented allergies to excipients in commercial products, women who need doses not available in commercial formulations, or patients who have failed multiple FDA-approved options. For those patients, compounding pharmacies fill an important gap.

What it does mean: if you have access to FDA-approved HRT and no specific clinical reason to prefer compounding, major medical societies recommend starting there. Winona's model makes sense for patients who specifically want compounded formulations and understand the regulatory context.

---

What is the patient experience from signup to treatment?

Most patients describe the Winona intake as fast — roughly 15–20 minutes to complete the questionnaire. The async physician review typically happens within 24–48 hours. Prescription dispatch to the compounding pharmacy follows, with delivery timelines varying by pharmacy but generally running 5–10 business days for the first order.

What works well:

• Low friction: no video appointment scheduling, no waiting for an opening
• Physician-reviewed prescriptions rather than protocol-driven PA/NP approvals
• Flexible formulations: topical, oral, and vaginal delivery options based on the patient's preference and symptoms
• Transparent monthly pricing with no separate consultation fees

Where friction tends to appear:

• Compounding pharmacy timelines are less predictable than commercial pharmacy fulfillment. First orders can run longer than expected, and refill timing requires attention.
• Dose titration without in-person support requires patient self-advocacy. Patients experiencing partial symptom relief need to communicate clearly through the async messaging system; the process for adjusting a dose is slower than a clinic visit.
• Without required lab work, early weeks on treatment can involve a symptom-guided adjustment period that might have been shorter with baseline hormone levels as a reference point.

Follow-up quality is correlated with how actively patients use the messaging system. The quarterly check-in structure means problems between scheduled reviews depend on the patient initiating contact.

---

What are the pros and cons of Winona?

Pros

• Physician-prescriber model — not NP/PA-only
• All-in monthly pricing with no hidden consultation or refill fees
• Customizable compounded formulations across multiple delivery methods
• Streamlined async intake — no video appointment required
• Optional lab work rather than mandatory, keeping the cost model accessible
• Founded 2019; established operating history in telehealth BHRT

Cons

• Prescribes compounded BHRT only — no FDA-approved finished HRT products (estradiol patches, Prometrium capsules, etc.)
• Lab testing is optional, not standard — baseline hormone data is not built into the protocol by default
• Async-only model means no live video consultation with your prescribing physician
• Compounding pharmacy shipping timelines can be slower and less predictable than standard pharmacy
• Cash-pay only — insurance not accepted
• Not appropriate for women with complex medical histories, significant cardiovascular risk, or personal history of breast cancer without specialist involvement

---

How does Winona compare to Midi Health?

Winona and Midi Health are the two most commonly compared menopause telehealth platforms. They serve overlapping patient populations but operate quite differently.

Midi Health offers live video consultations with menopause-trained clinicians, prescribes both FDA-approved HRT products and compounded formulations, and accepts insurance in many cases. Midi's clinical model resembles a menopause specialist clinic operating via telehealth — patients have a real-time relationship with their prescriber, treatment decisions can be adjusted in real time during visits, and insurance coverage reduces or eliminates out-of-pocket costs for eligible patients.

Winona runs on an async model with lower monthly cash-pay pricing, prescribes only compounded formulations, and does not accept insurance.

	Winona	Midi Health
Care model	Async (questionnaire + messaging)	Live video consultations
Prescriptions	Compounded BHRT only	FDA-approved HRT + compounded options
Insurance	Cash-pay only	Insurance accepted in many states
Monthly cost	$99–$199/month	Varies; often lower with insurance
Lab work	Optional (~$99 add-on)	Typically required or recommended
Video visits	Not required; not standard	Core to the model
Prescriber type	Licensed physicians	Menopause-certified clinicians

Which platform to choose: If you want FDA-approved HRT, use insurance, or want a live video relationship with your prescriber, Midi Health is the stronger clinical choice. If you specifically want compounded BHRT, prefer async convenience, and are paying cash, Winona delivers that model at a reasonable price point.

Neither platform is appropriate as a substitute for specialist evaluation if you have complex health history. Both are suited to otherwise healthy women with straightforward menopause symptom profiles.

---

Is Winona legitimate?

Yes. Winona is a legitimate telehealth platform. It has operated since 2019, employs licensed physicians to review and sign prescriptions, and fulfills orders through licensed compounding pharmacies operating under state pharmacy board oversight. The platform operates within US telehealth prescribing regulations.

The "is Winona legit" question usually conflates two separate concerns: whether the company is real and operates lawfully (yes), and whether compounded BHRT is a clinically appropriate and safe approach to menopause (more complicated).

On the second question: compounded BHRT is legal and can be clinically appropriate in the right context, but it operates outside the FDA's drug approval framework. That does not make it fraudulent — it is a meaningful regulatory distinction that patients should understand before choosing a compounding-based platform. The ACOG and NAMS recommend FDA-approved HRT products as first-line options for most patients. That recommendation exists because of safety and efficacy data, not because of commercial interests in brand-name drugs.

Winona's physician-prescriber model and transparent pricing are genuine positives. The platform does not misrepresent what it offers. The marketing language around "bioidentical" and "personalized" hormones reflects the category's conventions more than Winona-specific problems — but patients should translate that language rather than accept it at face value.

For editorial transparency: this review was produced independently. We have no commercial relationship with Winona, Midi Health, or any platform discussed. Read more about our editorial process and independence.

---

Frequently asked questions about Winona

Is Winona legit?

Yes. Winona is a legitimate telehealth platform staffed by licensed physicians, operating since 2019. Prescriptions are filled through licensed compounding pharmacies. The platform operates within US telehealth prescribing regulations. The more nuanced question is whether compounded BHRT is the right clinical choice for your specific situation — see the BHRT vs FDA-approved HRT section above.

How much does Winona cost per month?

$99–$199/month depending on protocol and formulation. That price covers the physician review, compounded prescription, pharmacy fulfillment, and ongoing async follow-up. No separate consultation fees or refill charges. Optional hormone lab panels run approximately $99 as an add-on. Insurance is not accepted.

Does Winona require lab work before prescribing?

No. Lab testing is optional. Treatment can start based on the symptom questionnaire alone. An optional hormone panel (~$99) is available for patients who want baseline lab data. Starting without labs is possible but limits the precision of initial dosing.

What hormones does Winona prescribe?

Compounded bioidentical estrogen (typically estriol and/or estradiol), progesterone, and testosterone. Delivery methods — oral, topical cream, vaginal suppository — vary by patient based on the symptom intake.

How does Winona compare to Midi Health?

Midi Health uses live video consultations, prescribes FDA-approved HRT options alongside compounded formulations, and accepts insurance. Winona is async-only, compounded BHRT only, and cash-pay only. Women who want FDA-approved HRT, insurance coverage, or video visits should consider Midi Health. Women who want compounded BHRT at a cash-pay price without scheduling video appointments fit Winona's model better.

Can I use insurance with Winona?

No. Winona is cash-pay only and does not bill insurance. Compounded medications are generally not covered by insurance even through traditional providers. HSA/FSA eligibility varies — confirm with your plan administrator before paying.